Evolent Health Current Ratio 2014-2025 | EVH
Evolent Health current ratio from 2014 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Evolent Health Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-12-31 | $0.51B | $0.39B | 1.31 |
| 2025-09-30 | $0.57B | $0.43B | 1.33 |
| 2025-06-30 | $0.56B | $0.56B | 1.01 |
| 2025-03-31 | $0.73B | $0.74B | 0.99 |
| 2024-12-31 | $0.61B | $0.72B | 0.85 |
| 2024-09-30 | $0.54B | $0.52B | 1.04 |
| 2024-06-30 | $0.52B | $0.48B | 1.08 |
| 2024-03-31 | $0.67B | $0.66B | 1.02 |
| 2023-12-31 | $0.68B | $0.67B | 1.01 |
| 2023-09-30 | $0.64B | $0.62B | 1.04 |
| 2023-06-30 | $0.58B | $0.54B | 1.07 |
| 2023-03-31 | $0.48B | $0.46B | 1.04 |
| 2022-12-31 | $0.48B | $0.43B | 1.10 |
| 2022-09-30 | $0.39B | $0.38B | 1.03 |
| 2022-06-30 | $0.42B | $0.34B | 1.23 |
| 2022-03-31 | $0.46B | $0.38B | 1.21 |
| 2021-12-31 | $0.52B | $0.45B | 1.18 |
| 2021-09-30 | $0.48B | $0.37B | 1.30 |
| 2021-06-30 | $0.51B | $0.40B | 1.25 |
| 2021-03-31 | $0.51B | $0.42B | 1.23 |
| 2020-12-31 | $0.55B | $0.40B | 1.36 |
| 2020-09-30 | $0.55B | $0.37B | 1.50 |
| 2020-06-30 | $0.28B | $0.25B | 1.12 |
| 2020-03-31 | $0.26B | $0.24B | 1.09 |
| 2019-12-31 | $0.23B | $0.19B | 1.19 |
| 2019-09-30 | $0.31B | $0.26B | 1.19 |
| 2019-06-30 | $0.24B | $0.17B | 1.39 |
| 2019-03-31 | $0.32B | $0.16B | 1.96 |
| 2018-12-31 | $0.49B | $0.27B | 1.81 |
| 2018-09-30 | $0.35B | $0.14B | 2.50 |
| 2018-06-30 | $0.35B | $0.14B | 2.59 |
| 2018-03-31 | $0.34B | $0.12B | 2.88 |
| 2017-12-31 | $0.38B | $0.13B | 2.85 |
| 2017-09-30 | $0.35B | $0.11B | 3.34 |
| 2017-06-30 | $0.19B | $0.10B | 1.89 |
| 2017-03-31 | $0.22B | $0.10B | 2.08 |
| 2016-12-31 | $0.27B | $0.13B | 2.01 |
| 2016-09-30 | $0.19B | $0.07B | 2.93 |
| 2016-06-30 | $0.17B | $0.06B | 3.01 |
| 2016-03-31 | $0.17B | $0.05B | 3.19 |
| 2015-12-31 | $0.18B | $0.06B | 3.10 |
| 2015-09-30 | $0.25B | $0.09B | 2.74 |
| 2015-06-30 | $0.25B | $0.06B | 4.14 |
| 2015-03-31 | $0.05B | $0.05B | 0.87 |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
| 2013-12-31 | $0.08B | $0.03B | 2.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.311B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |